» Articles » PMID: 33677310

Total Glucosides of Paeony Protects THP-1 Macrophages Against Monosodium Urate-induced Inflammation Via MALAT1/miR-876-5p/NLRP3 Signaling Cascade in Gouty Arthritis

Overview
Date 2021 Mar 7
PMID 33677310
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Monosodium urate (MSU)-mediated inflammatory response is a crucial inducing factor in gouty arthritis. Here, we explored the underlying mechanism of total glucosides of paeony (TGP) in MSU-induced inflammation of THP-1 macrophages in gouty arthritis.

Methods: 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used to detect cell viability. Enzyme-linked immunosorbent assay (ELISA) was utilized to measure the production of interleukin 1β (IL-1β) and tumor necrosis factor α (TNF-α). Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot assay were conducted to determine RNA and protein expression. Dual-luciferase reporter assay, RNA immunoprecipitation (RIP) assay and RNA pull down assay were used to confirm the interaction between miR-876-5p and MALAT1 or NLR family pyrin domain containing 3 (NLRP3).

Results: MSU-induced damage and inflammatory response in THP-1 macrophages were alleviated by the treatment of TGP in a dose-dependent manner. Overexpression of NLRP3 or MALAT1 reversed the protective effects of TGP in MSU-induced THP-1 macrophages. The binding relation between miR-876-5p and MALAT1 or NLRP3 was identified in THP-1 macrophages. MALAT1 up-regulated the expression of NLRP3 by sponging miR-876-5p in THP-1 macrophages. TGP suppressed MSU-induced inflammation in THP-1 macrophages through regulating MALAT1/miR-876-5p/NLRP3 axis. TGP suppressed MSU-induced activation of TLR4/MyD88/NF-κB pathway through regulating MALAT1/miR-876-5p/NLRP3 axis.

Conclusion: In conclusion, TGP suppressed MSU-induced inflammation in THP-1 macrophages through regulating MALAT1/miR-876-5p/NLRP3 axis and TLR4/MyD88/NF-κB pathway, suggesting that TGP was a promising active ingredient for gouty arthritis treatment.

Citing Articles

Unraveling the impact of miRNAs on gouty arthritis: diagnostic significance and therapeutic opportunities.

Mageed S, Elimam H, Elesawy A, Abulsoud A, Raouf A, El Tabaa M Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39560752 DOI: 10.1007/s00210-024-03603-9.


TCM and related active compounds in the treatment of gout: the regulation of signaling pathway and urate transporter.

Sun X, Yang L, Sun H, Sun Y, Wei S, Han Y Front Pharmacol. 2023; 14:1275974.

PMID: 38094893 PMC: 10716793. DOI: 10.3389/fphar.2023.1275974.


Transcriptomic Analysis of THP-1 Cells Exposed by Monosodium Urate Reveals Key Genes Involved in Gout.

Wang G, Liu Z, Zheng Y, Sheng C, Hou X, Yao M Comb Chem High Throughput Screen. 2023; 27(18):2741-2752.

PMID: 37855355 DOI: 10.2174/0113862073262471231011043339.


Expression Profile of Pyroptosis-Related Genes and the Associated Regulatory Axis in Primary Gout Patients.

Niu S, Lei T, Dai F, Xie H, Yu X, Zhang Q J Inflamm Res. 2023; 16:1711-1725.

PMID: 37155429 PMC: 10122851. DOI: 10.2147/JIR.S407359.


Role of NLRP3 in the pathogenesis and treatment of gout arthritis.

Liu Y, Wang J, Li J Front Immunol. 2023; 14:1137822.

PMID: 37051231 PMC: 10083392. DOI: 10.3389/fimmu.2023.1137822.